November 8, 2007 - Point-of-care blood analysis systems company Abaxis Inc. said today the FDA granted waived status for its comprehensive metabolic panel, basic metabolic panel and electrolyte panel, allowing lab-accurate comprehensive health screenings in nearly any environment.
Four analytes for chloride (Cl-), potassium (K), sodium (Na), and total carbon dioxide (tCO2), were granted waived status by the FDA when used in conjunction with the Piccolo and Piccolo Xpress point-of-care analyzers.